Burling Wealth Partners LLC Invests $4.74 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Burling Wealth Partners LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 9,369 shares of the healthcare conglomerate’s stock, valued at approximately $4,740,000. UnitedHealth Group accounts for approximately 1.0% of Burling Wealth Partners LLC’s investment portfolio, making the stock its 29th largest holding.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

UNH opened at $428.25 on Thursday. The firm has a market cap of $391.73 billion, a price-to-earnings ratio of 27.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $417.12 and a 52 week high of $630.73. The business’s 50 day moving average is $506.92 and its two-hundred day moving average is $537.23. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the previous year, the business posted $6.91 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 35.18%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on UNH. Oppenheimer dropped their price objective on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating for the company in a research note on Monday. KeyCorp dropped their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research note on Monday. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Barclays decreased their price objective on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research note on Monday. Finally, HSBC reaffirmed a “hold” rating and issued a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $604.67.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.